Information Letter on clopidogrel: Risk of acquired haemophilia
2013.09.04
Active substance: clopidogrel
The marketing authorisation holders are circulating information on a small number of cases of acquired haemophilia associated with clopidogrel treatment in patients without a history of haemostasis.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN